Skip to main content
SpringerLink
Log in

Thyroglobulin as Specific Tumor Marker in Differentiated Thyroid Cancer

  • Chapter
Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashcraft MW, Herle AJ van (1981) The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 71:806–814

    Article  PubMed  Google Scholar 

  2. Bachelot A, Cailleux AF, Klain M, Baudin E, Ricard M, Bellon N, Caillou B, Travagli JP, Schlumberger M (2002) Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid 12:707–711

    Article  PubMed  Google Scholar 

  3. Baskin HJ, Atwood TM, Holcomb LP (2000) Recombinant and human thyrotropin stimulation in the follow-up of patients with stage I or II differentiated thyroid carcinoma. Endocr Pract 6:430–434

    PubMed  Google Scholar 

  4. Bayer MF, Kriss JP (1979) Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab 49:557–564

    PubMed  Google Scholar 

  5. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, Maussier L, Salvatori M, Rufini V, Reale F, Romano L, Tallini G, Zelano G, Pontecorvi A (2001) Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer 92:2273–2279

    Article  PubMed  Google Scholar 

  6. Benvenga S, Burek CL, Talor M, Rose NR, Trimarchi F (2002) Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in Hashimoto's thyroiditis and non-autoimmune thyroid diseases. J Endocrinol Invest 25:977–982

    PubMed  Google Scholar 

  7. Berding G, Hüfner M, Georgi P (1992) Thyroglobulin, 131I whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer. Nuklearmedizin 31:32–37

    PubMed  Google Scholar 

  8. Black EG, Sheppard MC, Hoffenberg R (1987) Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 27:115–120

    Google Scholar 

  9. Botsch H, Glatz J, Schulz E, Wenzel KW (1983) Long-term follow-up using serial serum thyroglobulin determinations in patients with differentiated thyroid carcinoma. Cancer 52:1856–1859

    PubMed  Google Scholar 

  10. Bourrel F, Hoff M, Regis H, Courriere P, Caron P (1998) Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests. Clin Chem Lab Med 36:725–730

    Article  PubMed  Google Scholar 

  11. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY (2002) Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215–221

    Article  Google Scholar 

  12. Colacchio TA, LoGerfo P, Colacchio DA, Feind C (1982) Radioiodine total body scan versus serum thyroglobulin levels in follow-up of patients with thyroid cancer. Surgery 91:42–45

    PubMed  Google Scholar 

  13. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Lo Gerfo PL (1996) Detection of circulating thyroid cells in peripheral blood. Surgery 120:959–964

    PubMed  Google Scholar 

  14. Do Rosario PW, Fagundes TA, Maia FF, Franco AC, Figueiredo MB, Purisch S (2004) Sonography in the diagnosis of cervical recurrence in patients with differentiated thyroid carcinoma. J Ultrasound Med 23:915–920

    PubMed  Google Scholar 

  15. Dow KH, Ferrell BR, Anello C (1997) Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7:613–619

    PubMed  Google Scholar 

  16. Dralle H, Schwarzrock R, Lang W, Bocker W, Ziegler H, Schroder S, Geerlings H (1985) Comparison of histology and immunohistochemistry with thyroglobulin serum levels and radioiodine uptake in recurrences and metastases of differentiated thyroid carcinomas. Acta Endocrinol (Copenh) 108:504–510

    PubMed  Google Scholar 

  17. Druetta L, Croizet K, Bornet H, Rousset B (1998) Analyses of the molecular forms of serum thyroglobulin from patients with Graves' disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and western blot. Eur J Endocrinol 139:498–507

    Article  PubMed  Google Scholar 

  18. Edmonds CJ, Willis CL (1988) Serum thyroglobulin in the investigation of patients presenting with metastases. Br J Radiol 61:317–319

    PubMed  Google Scholar 

  19. Erali M, Bigelow RB, Meikle AW (1996) ELISA for thyroglobulin in serum: recovery studies to evaluate autoantibody interference and reliability of thyroglobulin values. Clin Chem 42:766–770

    PubMed  Google Scholar 

  20. Eszlinger M, Neumann S, Otto L, Paschke R (2002) Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer. Eur J Endocrinol 147:575–582

    PubMed  Google Scholar 

  21. Eustatia-Rutten CF, Smit JW, Romijn JA, Kleij-Corssmit EP van der, Pereira AM, Stokkel MP, Kievit J (2004) Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) 61:61–74

    Article  Google Scholar 

  22. Fatemi S, LoPresti JS (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:4507–4508

    Google Scholar 

  23. Feldt-Rasmussen U, Schlumberger M (1988) European interlaboratory comparison of serum thyroglobulin measurement. J Endocrinol Invest 11:175–181

    PubMed  Google Scholar 

  24. Feldt-Rasmussen U, Hoier-Madsen M, Hansen HS, Blichert-Toft M (1986) Comparison between homogeneous phase radioassay and enzyme-linked immunosorbent assay for measurement of antithyroglobulin antibody content in serum. Relation to presence of thyroglobulin. Acta Pathol Microbiol Immunol Scand [C] 94:33–38

    Google Scholar 

  25. Feldt-Rasmussen U, Profilis C, Colinet E et al (1996a) Human thyroglobulin reference material (CRM 457). 1. Assessment of homogeneity, stability and immunoreactivity. Ann Biol Clin (Paris) 54:337–342

    Google Scholar 

  26. Feldt-Rasmussen U, Profilis C, Colinet E et al (1996b) A human thyroglobulin reference material (CRM 457). 2. Physicochemical characterization and certification. Ann Biol Clin (Paris) 54:343–348

    Google Scholar 

  27. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R (2003) Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:90–96

    PubMed  Google Scholar 

  28. Fugazzola L, Mihalich A, Persani L, Cerutti N, Reina M, Bonomi M, Ponti E, Mannavola D, Giammona E, Vannucchi G, di Blasio AM, Beck-Peccoz P (2002) Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 87:3201–3208

    PubMed  Google Scholar 

  29. Girelli ME, Busnardo B, Amerio R, Scotton G, Casara D, Betterle C, Piccolo M, Pelizzo MR (1985) Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy: study on 429 patients. Eur J Nucl Med 10:252–254

    Article  PubMed  Google Scholar 

  30. Girelli ME, Busnardo B, Amerio R, Casara D, Betterle C, Piccolo M (1986) Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus Tg levels after hormone withdrawal and total body scan: results in 291 patients with thyroid cancer. Eur J Nucl Med 11:333–335

    PubMed  Google Scholar 

  31. Görges R, Brandt-Mainz K, Freudenberg L, Frilling A, Grimm W, Bockisch A (2003a) Kontinuierliche Sensitivitätssteigerung in der Schilddrüsenkarzinom-Nachsorge im Verlauf dreier Thyreoglobulin-IMA-Generationen. Nuklearmedizin 42:157–166

    PubMed  Google Scholar 

  32. Görges R, Eising EG, Fotescu D, Renzing-Köhler K, Frilling A, Schmid KW, Bockisch A, Dirsch O (2003b) Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer. Eur J Ultrasound 16:191–206

    Article  PubMed  Google Scholar 

  33. Görges R, Tagay S, Matyssek K, Freudenberg L, Bockisch A, Langkafel M (2004) Einfluss der Schilddrüsenstoffwechsellage auf den psychosomatischen Status bei Schilddrüsenkarzinom-Patienten. In: Dietlein M, Schicha H (eds) Schilddrüse 2003: Zufallsbefund Schilddrüsenknoten — latente Schilddrüsenfunktionsstörungen. De Gruyter, Berlin, pp 374–80

    Google Scholar 

  34. Hjort T (1961) Determination of serum-thyroglobulin by a haemagglutination-inhibition test. Lancet 1:1262–1264

    PubMed  Google Scholar 

  35. Hocevar M, Auersperg M, Stanovnik L (1997) The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur J Surg Oncol 23:208–210

    Article  PubMed  Google Scholar 

  36. Hüfner M, Stumpf HP, Grussendorf M, Hermann HJ, Kimmig B (1983) A comparison of the effectiveness of 131I whole body scans and plasma Tg determinations in the diagnosis of metastatic differentiated carcinoma of the thyroid: a retrospective study. Acta Endocrinol (Copenh) 104:327–332

    PubMed  Google Scholar 

  37. Iervasi A, Iervasi G, Bottoni A, Boni G, Annicchiarico C, Cecco P di, Zucchelli GC (2004) Diagnostic performance of a new highly sensitive thyroglobulin immunoassay. J Endocrinol 182:287–294

    Article  PubMed  Google Scholar 

  38. Informationszentrum für Standards in der Onkologie (ISTO) (2001) Maligne Schilddrüsentumoren. Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Chirurgie, 3rd edn. http://www.uni-duesseldorf.de/WWW/AWMF/11/ (accessed 14 February 2005)

    Google Scholar 

  39. Kato R, Maruyama M, Sekino T, Kasuga Y (2000) A new assay for thyroglobulin concentration in serum using monoclonal antibodies against synthetic peptides. Clin Chim Acta 298:69–84

    PubMed  Google Scholar 

  40. Langkafel M, Tagay S, Schöpper N, Bockisch A, Senf W, Görges R (2004) Befindlichkeitsstörungen und Lebensqualität bei Schilddrüsenfunktionsstörungen — insbesondere bei Hypothyreose und Schilddrüsenkarzinom. In: Dietlein M, Schicha H (eds) Schilddrüse 2003: Zufallsbefund Schilddrüsenknoten — latente Schilddrüsenfunktionsstörungen. De Gruyter, Berlin, pp 357–362

    Google Scholar 

  41. Ligabue A, Poggioli MC, Zacchini A (1993) Interference of specific autoantibodies in the assessment of serum thyroglobulin. J Nucl Biol Med 37:273–279

    PubMed  Google Scholar 

  42. Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G (2002) Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. J Endocrinol Invest 25:110–115

    Google Scholar 

  43. Lubin E, Mechlis-Frish S, Zatz S, Shimoni A, Segal K, Avraham A, Levy R, Feinmesser R (1994) Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 35:257–262

    PubMed  Google Scholar 

  44. Mariotti S, Barbesino G, Caturegli P, Marino M, Manetti L, Pacini F, Centoni R, Pinchera A (1995) Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 80:468–472

    Article  PubMed  Google Scholar 

  45. Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9:421–427

    PubMed  Google Scholar 

  46. Mazzaferri EL, Kloos RT (2002) Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? J Clin Endocrinol Metab 87:1490–1498

    Article  PubMed  Google Scholar 

  47. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A (2003a) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441

    Article  PubMed  Google Scholar 

  48. Mazzaferri EL, Robbins RJ, Braverman LE, Pacini F, Haugen BR, Wartofsky L, Braunstein GD, Ladenson PW, Pinchera A (2003b) Authors response: a consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:4508–4510

    Article  Google Scholar 

  49. Menzel C, GrĂĽnwald F, Biersack HJ (2003) Monitoring of low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:4507

    Article  Google Scholar 

  50. Mommert C, Görges R, Brandt-Mainz K, Hüsing J, Mergner J, Bockisch A (2000) Outcome of 1,017 patients with differentiated thyroid carcinoma and detection of recurrences. Eur J Nucl Med 27:1156 (abstract PS581)

    Google Scholar 

  51. Morgenthaler NG, Froehlich J, Rendl J, Willnich M, Alonso C, Bergmann A, Reiners C (2002) Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin. Clin Chem 48:1077–1083

    PubMed  Google Scholar 

  52. Moriyama K, Akamizu T, Umemoto M, Miura M, Saijo M, Taniguchi K, Nakao K (1999) A case of Hashimotoʻs thyroiditis with markedly elevated serum thyroglobulin and evidence of its influence on the measurement of anti-thyroglobulin antibody by highly sensitive assays. Endocr J 46:687–693

    PubMed  Google Scholar 

  53. Morris LF, Waxman AD, Braunstein GD (2002) Interlaboratory comparison of thyroglobulin measurements for patients with recurrent or metastatic differentiated thyroid cancer. Clin Chem 48:1371–1372

    PubMed  Google Scholar 

  54. Müller-Gärtner HW, Schneider C, Tempel MT (1986) Serum-Thyreoglobulin in der Metastasendiagnostik des differenzierten Schilddrüsenkarzinoms. Nuklearmedizin 25:194–200

    PubMed  Google Scholar 

  55. Müller-Gärtner HW, Schneider C (1988) Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer. Cancer 61:976–981

    PubMed  Google Scholar 

  56. Pacini F, Lippi F (1999) Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement. J Endocrinol Invest 22[Suppl 11]:25–29

    PubMed  Google Scholar 

  57. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A (1985) Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 23:405–411

    Google Scholar 

  58. Pellegriti G, Scollo C, Regalbuto C, Attard M, Marozzi P, Vermiglio F, Violi MA, Cianci M, Vigneri R, Pezzino V, Squatrito S (2003) The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels. Clin Endocrinol (Oxf) 58:556–561

    Article  Google Scholar 

  59. Petrich T, Börner AR, Weckesser E, Soudah B, Otto D, Widjaja A, Hofmann M, Kreipe HH, Knapp WH (2001) Nachsorge des differenzierten Schilddrüsenkarzinoms unter Verwendung von rhTSH — vorläufige Ergebnisse. Nuklearmedizin 40:7–14

    PubMed  Google Scholar 

  60. Piechaczyk M, Baldet L, Pau B, Bastide JM (1989) Novel immunoradiometric assay of thyroglobulin in serum with use of monoclonal antibodies selected for lack of cross-reactivity with autoantibodies. Clin Chem 35:422–424

    PubMed  Google Scholar 

  61. Preissner CM, O`Kane DJ, Singh RJ, Morris JC, Grebe SK (2003) Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88:3069–3074

    Article  PubMed  Google Scholar 

  62. Quevedo I, Campino C, Rodriguez Portales JA, Arteaga E, Lopez JM, Campusano C, Gonzalez G, Fardella C, Slater J, Valdivia L, Poggi H, Foradori A, Velasco S (2002) Anti thyroglobulin antibodies in the follow-up of patients with differentiated thyroid cancer: residual or relapsing disease markers? Rev Med Chil 130:167–172

    PubMed  Google Scholar 

  63. Reiners C, Reimann J, Schaffer R, Baum K, Becker W, Eilles C, Gerhards W, Schick F, Spiegel W, Wiedemann W et al (1984) Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy. Röfo 141:306–313

    Google Scholar 

  64. Ringel MD, Balducci-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman KD, Wartofsky L, Ladenson PW, Levine MA, Tuttle RM (1999) Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 84:4037–4042

    Article  PubMed  Google Scholar 

  65. Roitt IM, Torrigiani G (1967) Identification and estimation of undegraded thyroglobulin in human serum. Endocrinology 81:421–429

    PubMed  Google Scholar 

  66. Ronga G, Fiorentino A, Paserio E, Signore A, Todino V, Tummarello MA, Filasi M, Baschieri I (1990) Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? J Nucl Med 31:1766–1771

    PubMed  Google Scholar 

  67. Sapin R, Gasser F, Chambron J (1992) Recovery determination in 600 sera analyzed for thyroglobulin with a recently commercialized IRMA kit. Clin Chem 38:1920–1921

    PubMed  Google Scholar 

  68. Schaadt B, Feldt-Rasmussen U, Rasmusson B, Torring H, Foder B, Jorgensen K, Hansen HS (1995) Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. Thyroid 5:165–170

    PubMed  Google Scholar 

  69. Schlumberger M, Pacini F (eds) (1999) Thyroid tumors. Serum thyroglobulin measurement, Chap 7.2.3. Éditions Nucléon, Paris, pp 136–140

    Google Scholar 

  70. Schlumberger M, Fragu P, Gardet P, Lumbroso J, Violot D, Parmentier C (1991) A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients. Eur J Nucl Med 18:153–157

    PubMed  Google Scholar 

  71. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A, Wiersinga WM (2004) Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150:105–112

    Article  PubMed  Google Scholar 

  72. Sheils OM, Sweeney EC (1999) TSH receptor status of thyroid neoplasms — TaqMan RTPCR analysis of archival material. J Pathol 188:87–92

    Article  PubMed  Google Scholar 

  73. Spencer CA, Takeuchi M, Kazarosyan M (1996); Current status and performance goals for serum thyroglobulin assays. Clin Chem 42:164–173

    PubMed  Google Scholar 

  74. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT (1998) Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121–1127

    Article  PubMed  Google Scholar 

  75. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT (1999) Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 9:435–441

    PubMed  Google Scholar 

  76. Sulman C, Gosselin P, Carpentier P, Lemaire B (1984) Value of the estimation of thyroglobulin levels in the surveillance of treated differentiated thyroid carcinoma. J Clin Chem Clin Biochem 22:215–218

    PubMed  Google Scholar 

  77. Szanto J, Vincze B, Sinkovics I, Karika Z, Daubner K, Peter I, Kazatsay I, Eckhardt S (1989) Postoperative thyroglobulin level determination to follow up patients with highly differentiated thyroid cancer. Oncology 46:99–104

    PubMed  Google Scholar 

  78. Thyroid Carcinoma Task Force (2001) CE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 7:202–220

    Google Scholar 

  79. Torlontano M, Crocetti U, D'Aloiso L, Bonfitto N, Di Giorgio A, Modoni S, Valle G, Frusciante V, Bisceglia M, Filetti S, Schlumberger M, Trischitta V (2003) Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 148:19–24

    Article  PubMed  Google Scholar 

  80. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzo G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402–3407

    Article  PubMed  Google Scholar 

  81. Van Herle AJ, Uller RP, Matthews NI, Brown J (1973) Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320–1327

    PubMed  Google Scholar 

  82. Van Wyngaarden K, McDougall IR (1997) Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue? Thyroid 7:343–346

    PubMed  Google Scholar 

  83. Verburg FA, Lips CJ, Lentjes EG, Klerk JM de (2004) Detection of circulating Tg-mRNA in the follow-up of papillary and follicular thyroid cancer: how useful is it? Br J Cancer 91:200–204

    PubMed  Google Scholar 

  84. Wang PW, Wang ST, Liu RT, Chien WY, Tung SC, Lu YC, Chen HY, Lee CH (1999) Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 84:4549–4553

    Article  PubMed  Google Scholar 

  85. Wartofsky L (2002) Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning. J Clin Endocrinol Metab 87:1486–1489

    Article  PubMed  Google Scholar 

  86. Weightman DR, Mallick UK, Fenwick JD, Perros P (2003) Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up. Cancer 98:41–47

    Article  PubMed  Google Scholar 

  87. Wunderlich G, Zöphel K, Crook L, Smith S, Smith BR, Franke WG (2001) A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin. Thyroid 11:819–824

    Article  PubMed  Google Scholar 

  88. Zöphel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG (2001) Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma. Nuklearmedizin 40:155–163

    PubMed  Google Scholar 

  89. Zöphel K, Wunderlich G, Smith BR (2003) Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid 13:861–865

    Article  PubMed  Google Scholar 

Download references

Authors
  1. R. Görges
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Bockisch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany

    H.-J. Biersack (Professor Dr. med.) (Professor Dr. med.)

  2. Klinik für Nuklearmedizin, Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    F. GrĂĽnwald (Professor Dr. med.) (Professor Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Görges, R., Bockisch, A. (2005). Thyroglobulin as Specific Tumor Marker in Differentiated Thyroid Cancer. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27845-1_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-27845-1_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22309-2

  • Online ISBN: 978-3-540-27845-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation